Comparison of angiography, CT arteriography and MR imaging in assessment of liver metastases treated by percutaneous transcatheter intraarterial chemotherapy

Liver

Volumn 17, Issue 5, 1997, Pages 260-266

  Mahfouz, Ahmed Emad ^a,b   Häring, Georg ^c   Hamm, Bernd ^b,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CAIRO UNIVERSITY   (Egypt)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemotherapy; Computed tomography; Digital subtraction angiography; Liver neoplasms; Magnetic resonance imaging

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAARTERIAL DRUG ADMINISTRATION; LIVER ARTERIOGRAPHY; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0030671468     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1997.tb01028.x     Document Type: Article

References (16)

1. KLOPP C T, ALFORD C, BATEMAN J, BERRY G N, WINSHIP T. Fractionated intraarterial cancer chemotherapy with methylhistamine hydrochloride. Ann Surg 1950: 123: 811-832.
2. KAPLAN W D, COME S E, TAKVORIAN R W, et al. Pulmonary uptake of technetium 99m macroaggregated albumin: a predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol 1984: 2: 1266-1269.
3. CHEN H S, GROSS J F. Intra arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980: 64: 31-40.
4. ENSMINGER W D, GYVES J W. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983: 10: 176-182.
5. MILLER A B, HOOGSTRATEN B, STAQUET M, WINKLER A. Reporting results of cancer treatment. Cancer 1981: 47: 207-214.
6. ROTH J, WALLNER B, SAFI F. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: evaluation with CT and angiography. Am J Roentgenol 1989: 153: 751-754.
7. FRIEDRICH M, BERGER T, BOSE-LANDGRAF J. Angiographische und computertomographische Befunde bei intraarterieller Zytostase kolorektaler Lebermetastasen. ROFO Fortschr Geb Rontgenstr Nuklearmed 1986: 145: 446-455.
8. HALL J T, KIM E E, CHARNSANGAVEJ C, WALLACE S, HAYNIE T P. Variable patterns of technetium 99m MAA perfusion in the therapeutically embolized liver. J Nucl Med 1989: 30: 1012-1017.
9. BLEDIN A G, KANTARJIAN H M, KIM E E, et al. Use of a totally implanted drug delivery system. 99mTc-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. Am J Roentgenol 1982: 139: 711-715.
10. ZIESSMAN H A, THRALL J H, YANG P J, et al. Hepatic arterial perfusion scintigraphy with Tc-99m-MAA. Radiology 1984: 152: 167-172.
11. TOMCZAK R, ZEITLER H, RILINGER N, et al. Stellenwert der Portangiographie bei der Verlaufskontrolle der lokoregionaren Chemotherapie. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1992: 157: 552-554.
12. DIDOLKAR M S, ELIAS E G, WHITLEY N O, et al. Unresectable hepatic metastases from carcinoma of the colon and rectum. Surg Gynecol Obstet 1985: 160: 429-436.
13. SCATARIGE J C, FISHMAN E K, SAKSOUK F A, SIEGELMAN S S. Computed tomography of calcified liver masses. J Comput Assist Tumogr 1983: 7: 83-89.
14. LETOURNEAU J G, THOMPSON W M, GOLDBERG M E, SNOVER D C, GRAGE T B, FRICK M P. Progressive CT appearance of hepatic metastases from colorectal carcinoma. Gastrointest Radiol 1988: 13: 145-151.
15. LYGIDAKIS N J, SAVANIS G, POTHOULAKIS J, KAPETANAKIS A. Transarterial locoregional immunostimulation and chemotherapy in patients with unresectable secondary liver tumours. Anticancer Res 1994: 14: 643-646.
16. HAMM B, THOENI R F, GOULD R G, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994: 190: 417-423.